T1	PROC 49 95	estudio prospectivo, aleatorizado y controlado
T2	PROC 138 149	tratamiento
#1	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	CHEM 153 163	tacrolimus
#2	AnnotatorNotes T3	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T4	PROC 169 184	inmunosupresión
#3	AnnotatorNotes T4	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T5	CHEM 195 214	inhibidores de mTor
#4	AnnotatorNotes T5	C2746052; MTOR Inhibitors; Pharmacologic Substance
T6	CHEM 217 227	tacrolimus
#5	AnnotatorNotes T6	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T7	PROC 272 296	serología del SARS-CoV-2
T8	Dose 308 324	una cuarta dosis
T9	CHEM 331 361	vacuna de ARNm contra COVID-19
T10	LIVB 365 374	pacientes
#6	AnnotatorNotes T10	C0030705; Patients; Patient or Disabled Group
T11	PROC 389 416	trasplante de órgano sólido
T12	Neg_cue 421 423	no
T13	Negated 428 438	respondido
T14	PROC 477 522	ensayo prospectivo, aleatorizado y controlado
T15	CHEM 565 579	antimetabolito
#7	AnnotatorNotes T15	C0003376; Antimetabolites; Pharmacologic Substance
T16	CHEM 583 593	tacrolimus
#8	AnnotatorNotes T16	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T17	CHEM 596 603	MMF/MPS
T18	PROC 609 624	inmunosupresión
#9	AnnotatorNotes T18	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T19	CHEM 635 645	tacrolimus
#10	AnnotatorNotes T19	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T20	CHEM 648 667	inhibidores de mTor
#11	AnnotatorNotes T20	C2746052; MTOR Inhibitors; Pharmacologic Substance
T21	LIVB 715 725	SARS-CoV-2
#12	AnnotatorNotes T21	C5203676; SARS-CoV-2; Virus
T22	Dose 737 753	una cuarta dosis
T23	CHEM 760 774	vacuna de ARNm
T24	DISO 785 793	COVID-19
#13	AnnotatorNotes T24	C5203670; COVID19 (disease); Disease or Syndrome
T25	LIVB 797 806	pacientes
#14	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
T26	PROC 807 839	trasplantados de órganos sólidos
T27	Neg_cue 844 846	no
T28	Negated 851 873	respondido previamente
T29	PROC 946 957	tratamiento
#15	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	CHEM 961 971	tacrolimus
#16	AnnotatorNotes T30	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T31	CHEM 974 984	tacrolimus
#17	AnnotatorNotes T31	C0085149; tacrolimus; Organic Chemical · Pharmacologic Substance
T32	CHEM 987 1004	inhibidor de mTOR
#18	AnnotatorNotes T32	C2746052; MTOR Inhibitors; Pharmacologic Substance
T33	LIVB 1012 1021	pacientes
#19	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	PROC 1022 1052	trasplantados de órgano sólido
T35	Neg_cue 1058 1060	no
T36	Negated 1067 1103	respondido a las tres primeras dosis
T37	CHEM 1110 1116	vacuna
#20	AnnotatorNotes T37	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T38	LIVB 1155 1163	paciente
#21	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Age 1164 1173	≥ 18 años
T40	LIVB 1174 1184	2.Paciente
T41	PROC 1185 1197	trasplantado
#22	AnnotatorNotes T41	C0040732; Transplantation; Therapeutic or Preventive Procedure
T42	Date 1198 1225	hace un año o más de un año
T43	ANAT 1229 1242	órgano sólido
T44	PHYS 1247 1263	Respuesta inmune
#23	AnnotatorNotes T44	C0301872
T45	Dose 1320 1327	3 dosis
T46	CHEM 1335 1360	vacuna de ARNm SARS-CoV-2
T47	PHYS 1364 1377	Función renal
#24	AnnotatorNotes T47	C0232804; Renal function; Organ or Tissue Function
T48	PROC 1390 1401	FG estimado
T49	PROC 1434 1474	cociente de proteína/creatinina en orina
T50	PROC 1495 1531	Consentimiento informado por escrito
T51	PROC 1561 1572	Diagnóstico
#25	AnnotatorNotes T51	C0011900; Diagnosis; Diagnostic Procedure
T52	DISO 1583 1638	rechazo mediado por células T o mediado por anticuerpos
T53	CHEM 1685 1712	vacuna contra el SARS-CoV-2
T54	DISO 1717 1746	Infección previa por COVID-19
T55	PROC 1763 1802	anticuerpos específicos del donante HLA
T56	DISO 1806 1812	Cáncer
#26	AnnotatorNotes T56	C0006826; Malignant Neoplasms; Neoplastic Process
T57	Neg_cue 1820 1830	excluyendo
T58	DISO 1834 1860	cáncer de piel no melanoma
#27	AnnotatorNotes T58	C0699893; Skin carcinoma; Neoplastic Process
T59	Negated 1834 1860	cáncer de piel no melanoma
T60	PHYS 1864 1872	Embarazo
#28	AnnotatorNotes T60	C0032961; Pregnancy; Organism Function
